PENSIONERS' VOICE AND SOUND TRACK APPEALS YOU "USE MASK""KEEP SOCIAL DISTANCE" "GHAR BATHO ZINDA RAHO" "STAY HOME SAVE LIVES"
DEAR FRIENDS, CONGRATS, YOUR BLOG CROSSED 3268000 HITS ON 01.02.2023 THE BLOG WAS LAUNCHED ON 23.11.2014,HAVE A GREAT DAY
VISIT 'PENSIONERS VOICE & SOUND TRACK' WAY TO CATCH UP ON PENSIONER RELATED NEWS!

Saturday 30 May 2020

Cost of Covid-19 -How our Group Mediclaim will.help

I found the following in a FAQ in the internet:

"What is the approximate cost of treatment of COVID-19 infection?

The cost of COVID-19 treatment in private hospital rooms comes around Rs 2 lakh in tier 3 cities, Rs 3 lakh in tier 2 cities and Rs 5 lakh in tier 1 cities. Similarly, COVID-19 treatment in private super-speciality hospital rooms would cost Rs 7 lakh in tier 2 cities and Rs 8 lakh in metros. In private super-speciality hospitals with ICU and ventilators the cost would be Rs 9 lakh in tier 2 state capital cities and Rs 12.5 lakh in metros. It is generally assumed that the treatment duration can be as long as 15 days. However, for people with pre-existing disease like diabetes, BP, Cardiac or with Chest-related disease history, the cost of treatment can be as high as Rs 18 – 20 lakh."

If unfortunately any of the members covered by our Group Mediclaim Policy  are afflicted by Covid-19 ,the cost of treatment expenses can be prohibitive especially in the context of the expose that was telecast in Times Now TV News channel yesterday.

All the pensioners' Associations need to be alert to ensure that the affected pensioners and their family members are not fleeced by the Private Hospitals in the country considering our experience with the TPAs who are known to be tightening in the matter of giving approvals for treatment expenses in cashless Hospitalisation.There is a need to take up the matter with LIC Management so that LIC has proper coordination with NIA and pensioners are not put to undue financial strain in such contingencies.There is also increase in premium this year to the extent of about 12% over the previous year.

C H Mahadevan


No comments: